Viridian Therapeutics, Inc.
VRDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001590750
In the last 90 days, Viridian Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 214 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Viridian Therapeutics, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 55 | 72 | +17 |
| Shares | 23.3M | 24.9M | +1.67M (+7.2%) |
| Value | $459.8M | $460.9M | +$1.09M (+0.2%) |
New holders (20)
Institutions that held Viridian Therapeutics, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 1,739,530 | $32.2M | 2.74% |
| Susquehanna International Group, LLP | 97,527 | $1.80M | 0.00% |
| Goldman Sachs Group Inc | 66,598 | $1.23M | 0.00% |
| Jane Street Group, LLC | 61,518 | $1.14M | 0.00% |
| Squarepoint Ops LLC | 61,390 | $1.14M | 0.01% |
| Affinity Asset Advisors, LLC | 50,000 | $925.0K | 0.37% |
| HighVista Strategies LLC | 49,065 | $907.0K | 0.58% |
| HRT Financial LP | 24,092 | $445.0K | 0.00% |
| Bank of Montreal | 23,000 | $414.0K | 0.00% |
| Ensign Peak Advisors, Inc | 21,405 | $396.0K | 0.00% |
| Barclays PLC | 17,000 | $314.0K | 0.00% |
| Balyasny Asset Management LLC | 16,303 | $301.0K | 0.00% |
| Weiss Asset Management LP | 15,000 | $277.0K | 0.01% |
| Sciencast Management LP | 14,745 | $275.0K | 0.06% |
| Cannon Global Investment Management, LLC | 12,600 | $233.0K | 0.17% |
| Gyon Technologies Capital Management, LP | 12,187 | $225.0K | 0.16% |
| Royal Bank of Canada | 6,937 | $128.0K | 0.00% |
| Dorsey Wright & Associates | 2,511 | $46.0K | 0.01% |
| Cutler Group LP | 1,550 | $28.0K | 0.00% |
| Ovata Capital Management Ltd | 400 | $7.00K | 0.00% |
Sold out (3)
Institutions that held Viridian Therapeutics, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Frazier Management LLC | 1,505,200 | $29.8M |
| Schonfeld Strategic Advisors LLC | 21,512 | $425.0K |
| Sender Co & Partners, Inc. | 12,216 | $242.0K |